All clinical trials on the European Union Clinical Trials Register (EUCTR) must report their results in the registry within a year of completion. This site tracks who's doing this and who isn't. Learn more »
These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
Status | Trial ID | Title | Completion date | Category |
---|---|---|---|---|
Ongoing | 2004-004212-23 | Randomized study with oral tegafur versus capecitabina in the treatment of advanced politreated breast cancer and refractory, resistant or in progression to the standard chemotherapeutic treatment | not-yet-due | |
Ongoing | 2005-003814-14 | Pharmacodynamic study of Erlotinib (Tarceva) in patients with mestastatic or locally advanced Epidermoid carcinoma of the head and neck | not-yet-due | |
Ongoing | 2005-005738-11 | Phase II Study of Single Agent RAD001 in Patients with Colon Cancer and Activating Mutations in the PI3KCA gene. | not-yet-due | |
Ongoing | 2005-006171-12 | Estudio del tratamiento combinado, en primera línea, de capecitabina administrada de forma continua, oxaliplatino y bevacizumab administrado bisemanalmente en pacientes con adenocarcinoma colorrectal... | not-yet-due |